Patent details

EP1857122 Title: Stabilised mRNA with increased G/C content, coding for a viral antigen

Basic Information

Publication number:
EP1857122
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP070158357
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
Stabilised mRNA with increased G/C content, coding for a viral antigen
French Title of Invention:
ARNm stabilisé avec un contenu augmenté en G/C, codant pour un antigène virale
German Title of Invention:
Stabilisierte mRNA mit erhöhtem G/C-Gehalt, kodierend für ein virales Antigen
SPC Number:

Dates

Filing date:
05/06/2002
Grant date:
01/12/2010
EP Publication Date:
01/12/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/11/2007
EP B1 Publication Date:
01/12/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/06/2011
Expiration date:
05/06/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2002
 
 

Name:
CureVac GmbH
Address:
Paul-Ehrlich-Strasse 15, 72076 Tübingen, Germany (DE)

Inventor

1

Name:
Hoerr Ingmar
Address:
Germany (DE)

2

Name:
von der Mülbe Florian
Address:
Germany (DE)

3

Name:
Pascolo Steve
Address:
Germany (DE)

Priority

Priority Number:
10127283
Priority Date:
05/06/2001
Priority Country:
Germany (DE)

Classification

Main IPC Class:
C07K 14/11;
Filing date Document type Number of pages